Trial ID or NCT#

NCT01583218

Status

RECRUITING

Purpose

The purpose of this study is to evaluate whether extended prophylaxis with oral betrixaban can prevent blood clots in the leg and lung that sometime occur in patients hospitalized for an acute medical illness and to compare these results with standard of care enoxaparin. The safety of betrixaban will also be studied.

Official Title

(Apex) Multicenter, Randomized, Active-Controlled Efficacy And Safety Study Comparing Extended Duration Betrixaban With Standard Of Care Enoxaparin For The Prevention Of Venous Thromboembolism In Acute Medically Ill Patients

Eligibility Criteria

Ages Eligible for Study: Older than 40 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
View All Criteria

Investigator(s)

Ronald Pearl
Anesthesiologist
Dr. Richard K. and Erika N. Richards Professor

Contact us to find out if this trial is right for you.

CONTACT

APEX Study Clinical Trial Contact
(855) 256-7070

SEND MESSAGE

View on ClinicalTrials.gov